The Dialog Solutions brand has been integrated into Clarivate. Following the acquisition of Dialog Solutions as part of the ProQuest M&A in December 2021, Dialog Solutions products and services will be incorporated into the Clarivate portfolio of offerings for Life Sciences & Healthcare.
The migration of Dialog Solutions products and services into the Clarivate portfolio further bolster solutions that support pharmacovigilance medical literature monitoring, patent research, systematic review literature searches, MDR literature review searches, as well as competitive and business intelligence research. Customers can leverage the combined expertise, data and technologies to make smarter and faster evidence-based decisions, boost research and clinical outcomes.
The Dialog Solutions website will be migrated over to clarivate.com, enabling these products and solutions to reach a broader global audience. In product applications, key solutions, e.g. the Dialog™ platform and Drug Safety Triager™ will be developed and marketed under the Clarivate brand.
This migration serves as another milestone which further strengthens Clarivate as a leading global provider of information and insights that can transform intelligence into the answers customers need for solving healthcare’s biggest challenges.
Click here to read the original press release.
